SCHEMBL4183372

SCHEMBL4183372

Cc1cccc(CCNc2nc(-c3ccc(F)c(F)c3)ncc2C(C(N)=O)c2ccccn2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT6 P42226 6/20 0.38
JAK3 P52333 1/20 0.38
NR3C2 P08235 1/20 0.37
METAP2 P50579 2/20 0.37
METAP1 P53582 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.35
TSHR P16473 2/20 0.35
USP1 O94782 1/20 0.35
WDR48 Q8TAF3 1/20 0.35
HIF1A Q16665 1/20 0.35
POLB P06746 1/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPK1 P28482 1/20 0.34
CYP2C19 P33261 1/20 0.34
GBA1 P04062 1/20 0.34
F2 P00734 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4183379 0.88 STAT6 (0.38) STAT6JAK3NR3C2SMN1; SMN2TSHR
SCHEMBL4178991 0.87 NAMPT (0.40) JAK3SMN1; SMN2HIF1AGBA1
SCHEMBL4183068 0.87 PTAFR (0.39) STAT6JAK3NR3C2SMN1; SMN2TSHR
SCHEMBL4185958 0.81 STAT6 (0.39) STAT6JAK3NR3C2SMN1; SMN2TSHR
SCHEMBL4179070 0.79 ROCK2 (0.41) NR3C2KDM4EGBA1
SCHEMBL13743133 0.78 KDM4E (0.46) SMN1; SMN2ALDH1A1HPGDKDM4EF2
SCHEMBL4185586 0.77 GBA1 (0.39) JAK3HIF1AGBA1
SCHEMBL4184004 0.76 GBA1 (0.44) JAK3SMN1; SMN2HIF1AGBA1
SCHEMBL13743367 0.74 FLT3 (0.45) STAT6JAK3SMN1; SMN2ALDH1A1CYP1A2
SCHEMBL4183367 0.74 CYP2C19 (0.37) JAK3METAP2METAP1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090198057-A1 Certain Chemical Entities, Compositions, and Methods CYTOKINETICS, INCORPORATED 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090198057-A1 Certain Chemical Entities, Compositions, and Methods MYLK, MYH2, MYH10 STAT6 2728/4885JAK3 2944/4885NR3C2 2394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.